Direct purchasers seek final nod for AstraZeneca, Handa settlements in US antitrust case over Seroquel XR
MLex Summary: Direct purchasers of Seroquel XR asked a US federal judge to grant final approval to settlements totaling $51.4 million with AstraZeneca and Handa Pharmaceuticals to resolve US antitrust claims...To view the full article, register now.
Already a subscriber? Click here to view full article